Transcriptional inhibition of oxytocin receptor expression in human myometrial cells by melatonin involves protein kinase C signaling.
BACKGROUND
Our laboratory recently characterized the expression of the melatonin receptors in the human myometrium and showed that the expression of these receptors is suppressed during late pregnancy.


OBJECTIVE
In an effort to understand better the significance of melatonin in the human myometrium, we explored the mechanisms through which this hormone influences the expression of the oxytocin receptor in vitro.


METHODS
The stable melatonin analog iodomelatonin was presented to cultured telomerase-immortalized myometrial cells of the human telomerase reverse transcriptase line under physiological doses and durations. Pharmacological inhibitors of melatonin binding, gene transcription, phospholipase C, and protein kinase C signaling were used to define the mechanism of melatonin action.


RESULTS
Our results reveal that melatonin significantly inhibits oxytocin receptor mRNA expression primarily via the melatonin 2 receptor. The melatonin-dependent decrease in oxytocin receptor transcripts involves suppression of gene transcription rather than enhanced rates of transcript degradation. Melatonin effects were abolished by pretreating the cells with the phospholipase C inhibitor U73122 or the protein kinase C inhibitor C1.


CONCLUSIONS
Melatonin, like oxytocin, can negatively regulate oxytocin receptor transcription in human myometrial cells via modulation of protein kinase C signaling. This is consistent with the hypothesis that the reduced melatonin receptor expression during late pregnancy, which occurs at a time when oxytocin receptors are up-regulated, may be physiologically important for the subsequent timing of labor.
Sharkey
James
J
Department of Biomedical Sciences, Florida State University College of Medicine, 1115 West Call Street, Tallahassee, Florida 32306-4300, USA.
Olcese
James
J
D002461:Cell Line, Transformed; D005260:Female; D015870:Gene Expression / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008550:Melatonin / Q000378:metabolism* / Q000494:pharmacology; D009215:Myometrium / Q000166:cytology / Q000502:physiology*; D011493:Protein Kinase C / Q000378:metabolism*; D018045:Receptors, Oxytocin / Q000235:genetics*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D014158:Transcription, Genetic / Q000502:physiology
D018045:Receptors, Oxytocin; D011493:Protein Kinase C; D008550:Melatonin